Use of 1,25(OH)2-vitamin D3 in prevention of renal osteodystrophy: preliminary observations.
作者信息
Baker L R, Muir J W, Cattell W R, Tucker K A, Sharman V L, Goodwin F J, Marsh F P, Hately W, Morgan A G, de Saintonge D M
出版信息
Contrib Nephrol. 1980;18:147-51. doi: 10.1159/000403282.
PMID:7353373
Abstract
Hypercalcaemia regularly occurs when "prophylactic" 1,25-dihydroxyvitamin D3 (1,25[OH)2D3) in a dose of 1.0 microgram daily is given to haemodialysis patients without clinical biochemical or radiological evidence of osteodystophy. This dose is too large for such patients. Hypercalcaemia may persist for several weeks after withdrawal of 1,25(OH)2D3, particularly when previous attempts at control by dosage reduction have failed. Hypercalcaemia is better managed by stopping 1,25(OH)2D3, albeit temporarily, than by reducing the dose.
摘要
相似文献
1
Use of 1,25(OH)2-vitamin D3 in prevention of renal osteodystrophy: preliminary observations.
Contrib Nephrol. 1980;18:147-51. doi: 10.1159/000403282.
2
Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.1,25-二羟维生素D3与24,25-二羟维生素D3在肾性骨营养不良长期治疗中的比较
Proc Eur Dial Transplant Assoc. 1980;17:543-7.
3
Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.
Lancet. 1978 Sep 30;2(8092 Pt 1):700-3. doi: 10.1016/s0140-6736(78)92702-2.
4
The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.1α(OH)D3和1α,25(OH)2D3对肾性骨营养不良患者骨骼的影响。
Am J Med. 1978 Jan;64(1):101-7. doi: 10.1016/0002-9343(78)90184-5.
5
Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
Contrib Nephrol. 1980;18:139-46. doi: 10.1159/000403281.
6
Calcitriol in dialysis patients.透析患者中的骨化三醇
Clin Pharmacol Ther. 1978 May;23(5):515-9. doi: 10.1002/cpt1978235515.
7
1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.1,25-二羟胆钙化醇在慢性透析中的作用。一项双盲对照研究。
Ann Intern Med. 1978 Jun;88(6):774-80. doi: 10.7326/0003-4819-88-6-774.
8
Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
Contrib Nephrol. 1980;18:72-81. doi: 10.1159/000403274.
9
Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.1,25(OH)₂D₃在肾性骨营养不良管理中的应用现状
Kidney Int. 1980 Oct;18(4):409-18. doi: 10.1038/ki.1980.154.
10
Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophy.
Q J Med. 1982;51(204):427-44.
引用本文的文献
1
Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.接受维持性血液透析的无症状甲状旁腺功能亢进患者口服1,25-二羟基维生素D3与安慰剂的双盲试验。
Br Med J (Clin Res Ed). 1981 Jun 13;282(6280):1919-24. doi: 10.1136/bmj.282.6280.1919.
Zotero 插件